Literature DB >> 22767422

Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.

Patrick A Hughes1, Andrea M Harrington, Joel Castro, Tobias Liebregts, Birgit Adam, Dallas J Grasby, Nicole J Isaacs, Lochana Maldeniya, Chris M Martin, Jenny Persson, Jane M Andrews, Gerald Holtmann, L Ashley Blackshaw, Stuart M Brierley.   

Abstract

OBJECTIVE: The gut is a major site of contact between immune and sensory systems and evidence suggests that patients with irritable bowel syndrome (IBS) have immune dysfunction. Here we show how this dysfunction differs between major IBS subgroups and how immunocytes communicate with sensory nerves.
DESIGN: Peripheral blood mononuclear cell supernatants from 20 diarrhoea predominant IBS (D-IBS) patients, 15 constipation predominant IBS (C-IBS) patients and 36 healthy subjects were applied to mouse colonic sensory nerves and effects on mechanosensitivity assessed. Cytokine/chemokine concentration in the supernatants was assessed by proteomic analysis and correlated with abdominal symptoms, and expression of cytokine receptors evaluated in colonic dorsal root ganglia neurons. We then determined the effects of specific cytokines on colonic afferents.
RESULTS: D-IBS supernatants caused mechanical hypersensitivity of mouse colonic afferent endings, which was reduced by infliximab. C-IBS supernatants did not, but occasionally elevated basal discharge. Supernatants of healthy subjects inhibited afferent mechanosensitivity via an opioidergic mechanism. Several cytokines were elevated in IBS supernatants, and levels correlated with pain frequency and intensity in patients. Visceral afferents expressed receptors for four cytokines: IL-1β, IL-6, IL-10 and TNF-α. TNF-α most effectively caused mechanical hypersensitivity which was blocked by a transient receptor potential channel TRPA1 antagonist. IL-1β elevated basal firing, and this was lost after tetrodotoxin blockade of sodium channels.
CONCLUSIONS: Distinct patterns of immune dysfunction and interaction with sensory pathways occur in different patient groups and through different intracellular pathways. Our results indicate IBS patient subgroups would benefit from selective targeting of the immune system.

Entities:  

Keywords:  2,4,6-trinitrobenzene sulphonic acid; Helicobacter Pylori—epidemiology; Irritable bowel syndrome; cytokine; functional bowel disorder; functional dyspepsia; gastro-oesophageal reflux disease; lower oesophageal sphincter; nerve—gut interactions; neurogastroenterology; pain; real time PCR; sensory neurons; visceral hypersensitivity; visceral nociception

Mesh:

Substances:

Year:  2012        PMID: 22767422     DOI: 10.1136/gutjnl-2011-301856

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  64 in total

1.  Genome-wide DNA methylation profiling of peripheral blood mononuclear cells in irritable bowel syndrome.

Authors:  S Mahurkar; C Polytarchou; D Iliopoulos; C Pothoulakis; E A Mayer; L Chang
Journal:  Neurogastroenterol Motil       Date:  2015-12-16       Impact factor: 3.598

Review 2.  What does irritable bowel syndrome share with non-alcoholic fatty liver disease?

Authors:  Antonella Scalera; Matteo Nicola Dario Di Minno; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 3.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

4.  Activation of intestinal spinal afferent endings by changes in intra-mesenteric arterial pressure.

Authors:  A Humenick; B N Chen; L Wiklendt; N J Spencer; V P Zagorodnyuk; P G Dinning; M Costa; S J H Brookes
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

5.  IBS: Distinct neuro-immune patterns defined in IBS subtypes.

Authors:  Katrina Ray
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-24       Impact factor: 46.802

Review 6.  Role of enteric neurotransmission in host defense and protection of the gastrointestinal tract.

Authors:  Keith A Sharkey; Tor C Savidge
Journal:  Auton Neurosci       Date:  2013-12-22       Impact factor: 3.145

7.  Assessment of Serum sTREM-1 as a Marker of Subclinical Inflammation in Diarrhea-Predominant Patients with Irritable Bowel Syndrome.

Authors:  Chao Du; Lijun Peng; Guanjun Kou; Peng Wang; Lin Lu; Yanqing Li
Journal:  Dig Dis Sci       Date:  2018-03-07       Impact factor: 3.199

Review 8.  Irritable bowel syndrome: a gut microbiota-related disorder?

Authors:  Yogesh Bhattarai; David A Muniz Pedrogo; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-11-23       Impact factor: 4.052

Review 9.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

10.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.